抗體的生物素化標記實驗要點：

1. 泛素D抗體規(guī)格 如在反應混合液中有疊氮鈉或游離氨基存在,會抑制標記反應。因此,蛋白質(zhì)在反應前要對 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析；

2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會有所不同,選擇不當則影響標記的效率,應先用幾個不同的分子比來篩選最適條件；

3.用NHSB量過量也是不利的,抗原的結(jié)合位點可能因此被封閉,導致抗體失活；

4.由于抗體的氨基不易接近可能造成生物素化不足,此時可加入去污劑如 Triton x-100, Tween20等；

5.當游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點時,或位于酶的催化位點時,生物素化會降低或損傷抗體蛋白的結(jié)合力或活性；

6.生物素還可能與不同的功能基團,如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價結(jié)合；

7.交聯(lián)反應后,應充分透析,否則,殘余的生物素會對生物素化抗體與親和素的結(jié)合產(chǎn)生競爭作用；

8.在細胞的熒光標記實驗中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對某些細胞可導致高本底。

產(chǎn)品訂購信息：
英文名稱  Anti-Ubiquitin D 

中文名稱   泛素D抗體規(guī)格 

別    名  Diubiquitin; FAT10; UBD 3; Ubd; UBD_HUMAN; Ubiquitin D; Ubiquitin like protein FAT10; Ubiquitin-like protein FAT10.

濃    度   1mg/1ml

規(guī) 格  0.2ml/200μg

抗體來源   Rabbit

克隆類型   polyclonal

交叉反應   Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Sheep 

產(chǎn)品類型   一抗  

研究領域     細胞生物 神經(jīng)生物學 細胞凋亡 細胞分化 淋巴細胞 b-淋巴細胞 泛素

蛋白分子量  predicted molecular weight: 18kDa

性    狀   Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from human Ubiquitin D 

亞    型   IgG

純化方法   affinity purified by Protein A

儲 存 液   Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4

泛素D抗體規(guī)格 產(chǎn)品應用    WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 FAT10, also designated Ubiquitin D or Diubiquitin, is a 165 amino acid protein encoded in the major histocompatibility complex (MHC) that consists of two domains which share significant homology with ubiquitin. Each domain contains two cysteines, along with a free C-terminal diglycine motif required for FAT10 conjugate formation. FAT10 is inducible by interferon-g and tumor necrosis factor a (TNF?). The FAT10 protein interacts with MAD2, a component of the spindle checkpoint, and plays a role in antigen presentation, cytokine response, apoptosis and mitosis. It may also regulate cell growth during dendritic cell or B cell activation and development. FAT10 mRNA is expressed mainly in some dendritic cells and lymphoblastoid lines and in other specific cells subsequent to interferon-g induction. The human FAT10 gene, designated UBD, maps to chromosome 6p21.3 and is overexpressed in the tumors of various epithelial cancers.

Function : Ubiquitin-like protein modifier which can be covalently attached to target protein and subsequently leads to their degradation by the 26S proteasome, in a NUB1L-dependent manner. Probably functions as a survival factor. Conjugation ability activated by UBA6. Promotes the expression of the proteasome subunit beta type-9 (PSMB9/LMP2). Regulates TNF-alpha-induced and LPS-mediated activation of the central mediator of innate immunity NF-kappa-B by promoting TNF-alpha-mediated proteasomal degradation of ubiquitinated-I-kappa-B-alpha. Required for TNF-alpha-induced p65 nuclear translocation in renal tubular epithelial cells (RTECs). May be involved in dendritic cell (DC) maturation, the process by which immature dendritic cells differentiate into fully competent antigen-presenting cells that initiate T cell responses. Mediates mitotic non-disjunction and chromosome instability, in long-term in vitro culture and cancers, by abbreviating mitotic phase and impairing the kinetochore localization of MAD2L1 during the prometaphase stage of the cell cycle. May be involved in the formation of aggresomes when proteasome is saturated or impaired. Mediates apoptosis in a caspase-dependent manner, especially in renal epithelium and tubular cells during renal diseases such as polycystic kidney disease and Human immunodeficiency virus (HIV)-associated nephropathy (HIVAN).

Subcellular Location : Nucleus. Cytoplasm. Accumulates in aggresomes under proteasome inhibition conditions.

Tissue Specificity : Constitutively expressed in mature dendritic cells and B cells. Mostly expressed in the reticuloendothelial system (e.g. thymus, spleen), the gastrointestinal system, kidney, lung and prostate gland.

Post-translational modifications : Can be acetylated.

Similarity : Contains 2 ubiquitin-like domains.

Database links : UniProtKB/Swiss-Prot: O15205.2

抗體的鑒定：

1）泛素D抗體規(guī)格 抗體的效價鑒定：不管是用于診斷還是用于,制備抗體的目的都是要求較高效價。不同的抗原制備的抗體,要求的效價不一。鑒定效價的方法很多,包括有試管凝集反應,瓊脂擴散試驗,酶聯(lián)免疫吸附試驗等。常用的抗原所制備的抗體一般都有約成的鑒定效價的方法,以資比較。如制備抗抗體的效價,一般就采用瓊脂擴散試驗來鑒定。

2）抗體的特異性鑒定：抗體的特異性是指與相應抗原或近似抗原物質(zhì)的識別能力?？贵w的特異性高,它的識別能力就強。衡量特異性通常以交叉反應率來表示。交叉反應率可用競爭抑制試驗測定。以不同濃度抗原和近似抗原分別做競爭抑制曲線,計算各自的結(jié)合率,求出各自在IC50時的濃度,并按公式計算交叉反應率。 

如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無窮大時,表示這一抗血清與其他抗原物質(zhì)的交叉反應率近似為0,即該血清的特異性較好。

3）抗體親和力：是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol?？贵w親和力的測定對抗體的篩選,確定抗體的用途,驗證抗體的均一性等均有重要意義。

CD34 CD34(多肽抗原)Multi-class antibodies規(guī)格： 0.5mg

Anti-CCP 瓜氨酸環(huán)肽抗體Multi-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh PCDHAC1 原鈣粘蛋白1抗體 規(guī)格 0.2ml

HA Kit Influenza 甲型 H3N2 (A/Brisbane/10/2007) 血凝素 (Hemagglutinin / HA) ELISA配對抗體 ELISA

TUSC5 英文名稱： 基因5抗體 0.2ml

MERTK 英文名稱： c-mer原癌基因酪酸激酶抗體 0.1ml

Anti-CCP 瓜氨酸環(huán)肽抗體Multi-class antibodies規(guī)格： 0.2ml

MRP2 (multidrug resistance-associated protein2) 多藥耐藥相關蛋白2Multi-class antibodies規(guī)格： 0.5mg

Anti-Annexin A1 膜粘連蛋白A1抗體Multi-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh Phospho-Bcr(Tyr177) 磷酸化T淋巴細胞受體抗體 規(guī)格 0.1ml

IgG間接法試劑盒配套試劑(各種動物) 96T/ELISA法 進口分裝

MPP6 英文名稱： 棕櫚?；さ鞍?抗體 0.2ml

DATF1 英文名稱： 死亡相關轉(zhuǎn)錄因子1抗體 0.1ml

Anti-Annexin A1 膜粘連蛋白A1抗體Multi-class antibodies規(guī)格： 0.2ml

Anti-Phospho-RIP2 (Ser176) /FITC 熒光素標記磷酸化受體結(jié)合絲氨酸蘇氨酸激酶2抗體IgGMulti-class antibodies規(guī)格： 0.2ml

ABCG1 peptide 三磷酸腺苷結(jié)合盒亞家族G1抗原Multi-class antibodies規(guī)格： 0.5mg

孤菲肽/痛敏肽抗體 Anti-Nociceptin 0.1ml

SOCS1 英文名稱： 細胞因子信號傳導抑制蛋白1抗體 0.1ml

Epac1 英文名稱： 環(huán)磷酸腺苷調(diào)節(jié)鳥嘌呤核苷酸交換因子1抗體 0.2ml

Rhesus antibody Rh phospho-p53BP1(Ser25/29) 磷酸化p53結(jié)合蛋白1抗體 規(guī)格 0.1ml

ABCG1 peptide 三磷酸腺苷結(jié)合盒亞家族G1抗原Multi-class antibodies規(guī)格： 0.5mg

大鼠亮?；拿?LAP)ELISA試劑盒 ，英文名： LAP ELISA Kit

人基質(zhì)金屬蛋白酶抑制因子4(TIMP-4)ELISA檢測試劑盒Humaissueinhibitorsofmetalloproteinase4,TIMP-4ELISAKit 96T/48T

小尾寒羊阿黑皮素原(POMC)免疫試劑盒 Small Tailed Han sheep Proopiomelanocoin,POMC ELISA kit

CLIAKitforOT(Humanoxytocin)ELISAKit人催產(chǎn)素規(guī)格：48T/96T

糖果阿斯巴塘(aspaame)含量酶連續(xù)循環(huán)反應比色法定量檢測試劑盒20次

ELISAKitIL-11人白介素11規(guī)格：48T/96T

大鼠半乳糖凝集素7(GAL7)ELISA試劑盒 ，英文名： GAL7 ELISA Kit

Human alpha hydroxybyrate dehydrogenase (HBDH) ELISA Kit 人α羥基脫氫酶(αHBDH)ELISA試劑盒

Hamstehyroxine-BindingGlobulinAssay,TBGELISAKit 倉鼠甲狀腺結(jié)合球蛋白(TBG)ELISA試劑盒 96T/48T 進口分裝

CLIAKitforColIVELISAKIT大鼠Ⅳ型膠原規(guī)格：48T/96T

細胞乙酰輔酶A膽固醇乙酰轉(zhuǎn)移酶(ACAT)活性比色法定量檢測試劑盒20次

RatClusterofdiffereiation3,CD3ELISAKit大鼠CD3分子(CD3)ELISA試劑盒規(guī)格：96T/48T

泛素D抗體規(guī)格 大鼠膽堿乙酰轉(zhuǎn)移酶(ChAT)ELISA試劑盒 ，英文名： ChAT ELISA Kit

Porcine platelet derived growth factor (PDGF) ELISA Kit 豬血小板衍生生長因子(PDGF)ELISA試劑盒

ELISA 小鼠Active Caspase-8 48T/96T 進口分裝

CLIAKitforLPA(MouseL-phenylalanine)ELISAKit小鼠苯氨酸規(guī)格：48T/96T

通用型1毫升1厘米光徑石英比色皿1個

ELISAKitEGF雞表皮生長因子規(guī)格：48T/96T